Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes.
Haberger M, Bomans K, Diepold K, Hook M, Gassner J, Schlothauer T, Zwick A, Spick C, Kepert JF, Hienz B, Wiedmann M, Beck H, Metzger P, Mølhøj M, Knoblich C, Grauschopf U, Reusch D, Bulau P.
Haberger M, et al. Among authors: wiedmann m.
MAbs. 2014 Mar-Apr;6(2):327-39. doi: 10.4161/mabs.27876. Epub 2014 Jan 17.
MAbs. 2014.
PMID: 24441081
Free PMC article.